Search

everythinglearnresearchcommunity

for

Search:↓

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Ninjin'yoeito, a Japanese medicine, helped stop hair loss and improved mood in two post-COVID-19 patients.

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

Finasteride may help reduce COVID-19 infection by altering a key gene.

Countries with stricter cultures had fewer COVID-19 cases and deaths, paranoia is linked to false memories, psychosocial intervention works as well with or without antipsychotic drugs for young people with psychosis, smartphones can detect changes in behavior indicating illness relapse, and recruitment agents show regional and gender biases.

Long COVID in Japan involves persistent symptoms like fatigue and may be caused by lasting organ damage and prolonged inflammation, with vaccination as a potential treatment.

The document says hair loss can happen after recovering from COVID-19 and it can cause psychological discomfort.

Long-COVID symptoms can last more than a year and change over time.

People with no symptoms or mild COVID-19 have lower antibody levels, increasing their risk of getting COVID-19 again.

Men may be more vulnerable to severe COVID-19 due to genetic and hormonal factors, but more research is needed.

Hair loss occurred after a COVID-19 infection.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Skin and mucosal issues can occur after COVID-19 in adults and children.

The editorial stresses the importance of COVID-19 vaccination and ongoing contributions to the journal.

A woman's sudden hair loss was linked to her previous COVID-19 infection.

Treating post-COVID hair loss leads to full recovery, while not treating it often results in ongoing symptoms.

A functional medicine approach may help long COVID patients by focusing on adrenal fatigue, gut health, and vitamin D deficiency, using diagnostic tools and lifestyle changes.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

The document corrects an author's affiliation in previous articles about COVID-19 and its links to hair loss and hormones.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Long COVID affects many body systems and needs careful management.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Some Moroccan medicinal plants may contain compounds that can inhibit the virus causing COVID-19.

Experts agree on the need for standardized definitions and education for post-COVID-19 conditions.

Hair loss may be a delayed side effect of Multisystem Inflammatory Syndrome in children after COVID-19.

A woman developed skin lesions after PRP injections, possibly linked to COVID-19 infection and vaccination.

The DNA convention was a valuable opportunity for learning and networking, especially after COVID-19.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.